FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/02/023624 [Registered on: 27/02/2020] Trial Registered Prospectively
Last Modified On: 26/02/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to compare the efficacy of local Anaesthetic (Ropivacaine) alone and in combination with opiod or ketamine as adjuvent in periphral nerve block for Pain Relief following Breast surgery  
Scientific Title of Study   A study to compare the efficacy of ropivacaine alone and in combination with fentanyl or ketamine in modified pectoral block (PEC II) for analgesia following modified radical mastectomy (MRM)  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shashi Kiran 
Designation  Senior Professor 
Affiliation  Department of Anaesthesia and Critical Care Pt B.D.Sharma PGIMS  
Address  Department of Anaesthesiology and Critical care Pt B.D.Sharma PGIMS,

Rohtak
HARYANA
124001
India 
Phone  9416763899  
Fax    
Email  DrShashi64@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Davender Chahal 
Designation  PG student 
Affiliation  Department of Anaesthesia and Critical Care Pt B.D.Sharma PGIMS  
Address  Department of Anaesthesiology and Critical care Pt B.D.Sharma PGIMS,

Rohtak
HARYANA
124001
India 
Phone  9728069762  
Fax    
Email  jgdchahal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Davender Chahal 
Designation  PG student 
Affiliation  Department of Anaesthesia and Critical Care Pt B.D.Sharma PGIMS  
Address  Department of Anaesthesiology and Critical care Pt B.D.Sharma PGIMS,

Rohtak
HARYANA
124001
India 
Phone  9728069762  
Fax    
Email  jgdchahal@gmail.com  
 
Source of Monetary or Material Support  
Institutional,Pt B.D.Sharma PGIMS Rohtak (Haryana) 124001 
 
Primary Sponsor  
Name  Department of Anaesthesia and Critical Care  
Address  Pt B.D.Sharma PGIMS Rohtak (Haryana) 124001  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Davender chahal  Pt B.D.Sharma PGIMS   Department of Anaesthesia and Critical Care Pt B.D.Sharma PGIMS
Rohtak
HARYANA 
9728069762

jgdchahal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Modified pectoral blockPEC II is given for analgesia in Modified Radical Mastectomy with Ropivacaine alone  Requirement of rescue analgesic in modified pectoral block PEC II for analgesia in Modified Radical Mastectomy postoperatively  
Comparator Agent  Modified pectoral blockPEC II is given for analgesia in Modified Radical Mastectomy with Ropivacaine plus Fentanyl  Requirement of rescue analgesic in modified pectoral blockPEC II for analgesia in Modified Radical Mastectomy postoperatively 
Comparator Agent  Modified pectoral blockPEC II is given for analgesia in Modified Radical Mastectomy with Ropivacaine plus Ketamine  Requirement of rescue analgesic in modified pectoral blockPEC II for analgesia in Modified Radical Mastectomy postoperatively  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  All women aged between 20-60 years, belonging to American Society of Anesthesiologists (ASA) physical status I-III undergoing modified radical mastectomy (MRM) under general anaesthesia will be included in this study. 
 
ExclusionCriteria 
Details  Patients having contraindication to regional block, history of local anaesthetic allergy, psychiatric disorders, chronic opioid use, chachexic women and refusal to participate in the study will not been included. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Intraoperative haemodynamic monitoring
2. Postoperative haemodynamic monitoring
3. Time of first request for 1st rescue analgesic (injection Diclofenac sodium 75mg intravenously)
4. Time of first request for 2nd rescue analgesic (injection Tramadol 50mg intravenously)
5. Diclofenac sodium & Tramadol consumption in surgical ward
6. VAS Score
7. Nausea score
8. Sedation score
9. Side effects observed a)Hypotension b)Bradycardia c) any other
10. Antiemetics required
 
1. Intraoperative haemodynamic monitoring
2. Postoperative haemodynamic monitoring
3. Time of first request for 1st rescue analgesic (injection Diclofenac sodium 75mg intravenously)
4. Time of first request for 2nd rescue analgesic (injection Tramadol 50mg intravenously)
5. Diclofenac sodium & Tramadol consumption in surgical ward
6. VAS Score
7. Nausea score
8. Sedation score
9. Side effects observed a)Hypotension b)Bradycardia c) any other
10. Antiemetics required
 
 
Secondary Outcome  
Outcome  TimePoints 
1. Intraoperative haemodynamic monitoring
2. Postoperative haemodynamic monitoring
3. Time of first request for 1st rescue analgesic (injection Diclofenac sodium 75mg intravenously)
4. Time of first request for 2nd rescue analgesic (injection Tramadol 50mg intravenously)
5. Diclofenac sodium & Tramadol consumption in surgical ward
6. VAS Score
7. Nausea score
8. Sedation score
9. Side effects observed a)Hypotension b)Bradycardia c) any other
10. Antiemetics required
 
The following outcome messures will be assesed in all the three groups 1.Ropivacaine alone 2.Ropivacaine plus Fentanyl 3.Ropivacaine plus Ketamine after giving modified pectoral blockPEC II for analgesia in Modified Radical Mastectomy intra operatively and post operatively for 24 hrs.  
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   28/02/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

The aim and objective of the thesis is to evaluate Whether ropivacaine alone or in combination with fentanyl or ketamine will be effective analgesics for modified pectoral block in patients following modified radical mastectomy Adult patients aged between 18-60 years of Female sex belonging to American Society of Anesthesiologists (ASA) physical status I-III undergoing breast surgery under general anaesthesia will be included in this study and we will asses Intraoperative haemodynamic monitorin,Postoperative haemodynamic monitoring,Time of first request for 1st rescue analgesic (injection Diclofenac sodium 75mg intravenously),Time of first request for 2nd rescue analgesic (injection Tramadol 50mg intravenously),Diclofenac sodium & Tramadol consumption in surgical ward,VAS Score,Nausea score,Sedation score,Side effects observed a)Hypotension b)Bradycardia c) any other and Antiemetics required.Data will be copiled and appropriate stastical test will be done to analyse the result

 
Close